Colorectal peritoneal metastases and IMPACT

Similar documents
Patient Presentation. 32 y.o. female complains of lower abdominal mass CEA = 433, CA125 = 201

Information for health professionals - pseudomyxoma peritonei

Specialised Services Policy: CP02 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery for treatment of Pseudomyxoma Peritonei

Pre-operative assessment of patients for cytoreduction and HIPEC

Vic J. Verwaal, MD, PhD, 1 Sjoerd Bruin, MD, 1 Henk Boot, MD, PhD, 2 Gooike van Slooten, MD, 1 and Harm van Tinteren, ScM 3

Management of Pseudomyxoma Peritonei (PMP) and Colon Cancer Carcinomatosis by Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies

Regional Therapy for Management of Peritoneal Carcinomatosis from Gastrointestinal Malignancies

TREATMENT OF PERITONEAL COLORECTAL CARCINOMATOSIS

Heated Intraperitoneal Chemotherapy (HIPEC) for Advanced Abdominal Cancers

Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

Beate Rau, Charité University of Berlin Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei

Department of Surgery, Kusatsu General Hospital, Yabase Kusatsu 1660, Japan 2

Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer

Beate Rau, Campus Virchow-Klinikum, Berlin, DE François Quenet, Centre Régional du Cancer, Montpellier, Montpellier, FR

Author(s) Approval date: 12/05/16. Committee. June Operational Date: Review: Version No. 1.1 Supercedes 1.0 Links to other policies

HIPEC Controversies in the Indications and Application of Regional Chemotherapy for Peritoneal Surface Malignancies

Surgical Oncology, Mercy Medical Center, Baltimore, MD

Pseudomyxoma peritoni et al HOW TO TREAT PERITONEAL MALIGNANCIES

PERITONEAL CARCINOMATOSIS (PC) of colorectal origin

This is a submitted version of a paper published in European Journal of Surgical Oncology. Access to the published version may require subscription.

COLON AND RECTAL CANCER

APPLYING ENHANCED RECOVERY PRINCIPLES: EARLY TESTING IN UPPER GI CANCER

Unknown Primary Service for patients at Chesterfield Royal Hospital

Beate Rau, Charité Campus Berlin, Berlin, DE Tom Cecil, Basingstoke and North Hampshire Hospital, Basingstoke, UK

Gynaecological Oncology Cases

Appendix adenocarcinomas are rare and heterogeneous

CRS e HIPEC: Efficacia e Limiti

Marcello Deraco M.D. Responsible Peritoneal Malignancies

Ovarian cancer: clinical practice the Arabic perspective

Management of Stage IV Colorectal Cancer: Expanding the Horizon

Tariffs and Profitability for Gynaecological Oncology Services. Rob Gornall Gynaecological Oncologist Gloucestershire Hospitals FT

Management of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) after Cytoreductive Surgery (CRS)

Corporate Medical Policy

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

COLON AND RECTAL CANCER

1. Introduction. Correspondence should be addressed to Horacio N. López-Basave, Received 23 May 2011; Accepted 20 June 2011

U T C H. No disclosure

Epithelial ovarian cancer

Bowel Cancer Information Leaflet THE DIGESTIVE SYSTEM

Colorectal Liver Metastases Metachronous

Joseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital

Clinical Policy: Intraperitoneal Hyperthermic Chemotherapy for Abdominopelvic Cancers Reference Number: CP.MP. 346

SCAN Colorectal Group

Clinical Study Laparoscopic Cytoreductive Surgery and HIPEC in Patients with Limited Pseudomyxoma Peritonei of Appendiceal Origin

Understanding your bowel surgery

Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol

CT PET SCANNING for GIT Malignancies A clinician s perspective

Peritonectomy plus hyperthermic peritoneal perfusion for the treatment of peritoneal carcinosis H. Müller, MD, FACS

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease

Endometrial (womb) cancer

Acute Oncology Martin Eatock Consultant Medical Oncologist NICaN Medical Director

LCA Lung Clinical Forum. 21 st October 2014

Case Report Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Unconventional Indications

Co-ordinating care through multidisciplinary working

Faster Cancer Treatment Indicators: Use cases

Ghosts in the Machine: Jonathan B. Koea MD; FRACS. Department of Surgery Auckland Hospital Auckland New Zealand

Contents. Part 1. Peritoneal Carcinomatosis: Basic Concepts

Recovering at home. How will I feel when I get home? How should I look after my wound?

ABDOMINAL PERINEAL RESECTION. Patient information Leaflet

PARTICULARS, SCHEDULE 2- THE SERVICES, A- SERVICE SPECIFICATIONS. A08/S/d Colorectal: Faecal Incontinence (Adult)

Simple removal of the kidney (simple nephrectomy): procedure-specific information

How can we facilitate cross-boundary working in Greater Manchester?

To help you understand your operation, it is helpful to have a basic knowledge of how the body works (see Figure 1).

Colorectal multidisciplinary team. Information for patients

YOUR OPERATION EXPLAINED

Follow up The way ahead. John Griffith

Laparoscopy. Patient Information. Womens Health

Bowel Cancer in England and Wales A summary report about the management and outcomes of people with bowel cancer

Cancer of Unknown Primary (CUP) Protocol

BOWEL CANCER. Causes of bowel cancer

Please see the separate list of attendees and apologies uploaded on to the South West Clinical Network website here.

HARTMANNS PROCEDURE. Patient information Leaflet

2010 National Survey. East Kent Hospitals University NHS Trust

2010 National Survey. The North West London Hospitals NHS Trust

2010 National Survey. Royal National Orthopaedic Hospital NHS Trust

2010 National Survey. The Leeds Teaching Hospitals NHS Trust

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122

Rationale for the treatment. Peritoneal Surface Malignancy

2010 National Survey. University College London Hospitals NHS Foundation Trust

Laparotomy for large retroperitoneal mass:

Colorectal or bowel cancer

were here to help Macmillan Cancer Information and Support Centre Wexham Park Hospital, Slough

Ambulatory lung biopsy: a new model for the NHS. Dr Sam Hare Barnet Hospital Royal Free London NHS Trust

2010 National Survey. Northern Lincolnshire and Goole Hospitals NHS Foundation Trust

home.community: symptomatic relief of malignant ascites

BLADDER TUMOUR RESECTION

HIPEC treatment of peritoneal carcinomatosis in colorectal and gastric cancer Braam, Hidde

PRELIMINARY PROGRAM. 11 th International Workshop on Peritoneal Surface Malignancy SEPTEMBER 9-11,

Partial Removal of the Kidney

University College Hospital. Laparoscopic colorectal surgery. Gastrointestinal Services Division

Retroperineal Lymph Node Dissection (RPLND)

Radical removal of the kidney (radical nephrectomy): procedure-specific information

Laparoscopic Radical Removal of the Kidney +/- Ureter

CRS and HIPEC for Colorectal Cancer. Rajesh Nair, MD UF Health Cancer Center-Orlando Health March 11, 2017

Transcription:

Colorectal peritoneal metastases and IMPACT Vicki Pleavin-Evans Peritoneal Malignancy Clinical Nurse Specialist PMI Basingstoke Basingstoke and North Hampshire Hospital Aldermaston Road, Basingstoke, Hampshire RG24 9NA www.pmibasingstoke.com

Peritoneal Malignancy Institute First operation - 1994 National Referral Centre 2000 2 www.pmibasingstoke.com

Cytoreduction (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC) HIPEC 3 www.pmibasingstoke.com

4 www.pmibasingstoke.com

Sugarbaker technique - Cytoreduction Right hemicolectomy removal of the right side of the colon Greater omentectomy removal of the greater omentum Lesser omentectomy removal of the lesser omentum Splenectomy removal of the spleen Cholecystectomy removal of the gallbladder Anterior resection Total abdominal hysterectomy and bilateral oopherectomy 5 www.pmibasingstoke.com

Stripping of the peritoneum from the left hemidiaphragm Stripping of the peritoneum from the right hemidiaphragm Stripping of disease from the surface of the liver Pelvic Peritonectomy HIPEC If complete cytoreduction is not possible this is known as Maximal Tumour Debulking. 6 www.pmibasingstoke.com

Colorectal Peritoneal Metastases 7 www.pmibasingstoke.com

How Important is HIPEC? HIPEC HIPEC Complete Cytoreduction Complete cytoreduction 8 www.pmibasingstoke.com

CC score 9 www.pmibasingstoke.com

Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer Vic J. Verwaal, Serge van Ruth, Eelco de Bree, Gooike W. van Slooten, Harm van Tinteren, Henk Boot, and Frans A.N. Zoetmulder Journal of Clinical Oncology 2003 21:20, 3737-3743 Log Rank p = 0.0013 44% versus 24% at 2 years 10 www.pmibasingstoke.com

11 www.pmibasingstoke.com

5 year survival at least doubled 12 www.pmibasingstoke.com

National Institute for Health and Clinical Excellence CPM Commissioned in the UK 13 www.pmibasingstoke.com

Patient selection 14 www.pmibasingstoke.com

Peritoneal Cancer Index (Sugarbaker) PCI Consensus Milan 2006 PCI from 0 to 39 15 www.pmibasingstoke.com

16 www.pmibasingstoke.com

What does this mean for patients? 17 www.pmibasingstoke.com

Road to recovery Referral Inpatient treatment 6-8 week period post discharge Months 3-6 18 www.pmibasingstoke.com

Referral Clinical referral letter, CT imaging on IEP, histology, colonoscopy CRAM? SMDT OPA 19 www.pmibasingstoke.com

Initial appointment Main outpatient department 1 hour timeslot Consultant and Specialist Nurse Patient and relative Clinical, medical and social history Abdominal/rectal examination CT images viewed and explained 20 www.pmibasingstoke.com

Explanation of diagnosis Treatment/surveillance plan Letter dictated sometimes in front of patient Discussion with Specialist Nurse Written information provided Signpost to other agencies Baseline bloods to include CEA, CA125,CA19.9 21 www.pmibasingstoke.com

Common Concerns Work Mortgage and bills Travel Clothing Macmillan CAB Maggies Centre Away from home Visitors What to tell Children Hereditary? Fertility Macmillan CNS 22 www.pmibasingstoke.com

Stoma Intimate relations Scar Umbilicus removal Hair loss Stoma counselling GP CNS Complete? Length of stay Follow-up care Prognosis CNS GP Referring team 23 www.pmibasingstoke.com

Inpatient treatment 24 www.pmibasingstoke.com

25 www.pmibasingstoke.com

Length of stay 21 day overall average Shortest = 13 days Longest = 64 26 www.pmibasingstoke.com

Nursing the complex patient in a ward environment Complex care needs Epidural Management of chest drains Multiple abdominal drains Stoma care Analgesia Early mobilisation Nutrition Emotional distress 27 www.pmibasingstoke.com

Requirements for discharge Independently mobile Able to self care with ADL s Independent with stoma Understand operation and follow-up Ideally to have discussed histology Wound care 28 www.pmibasingstoke.com

Complications (12 months) 29 www.pmibasingstoke.com

Road to recovery 6-8 week period post discharge 30 www.pmibasingstoke.com

6-8 weeks post-discharge Decreased mobility Impact on family life Unable to drive Body image Bowel function Financial concerns Quality of life studies show this to be the most difficult period in the recovery phase. (Alves, S. 2010. Kirby, R. 2013) Emotional support 31 www.pmibasingstoke.com

Nurse-led telephone follow-up 1 week, 6 weeks and 3 months Follows a set structure Encompasses all aspects of recovery Letter sent to GP, patient, referring team and HHFT consultant OPA s made if required Extra calls scheduled according to need Open access service provided 32 www.pmibasingstoke.com

Road to recovery Months 3-6 33 www.pmibasingstoke.com

Months 3-6, adjusting to the new norm Pre-cancer Work Physical health Relationships Finances Mental health Beyond their clinical recovery, adjusting to their new lives, limitations, expectations, realities etc. can require coming to terms with a new version of themselves and of what their life is going to look like even if the actual change is relatively minor, the perception of change can have a significant impact in it s own right. 34 www.pmibasingstoke.com

Surveillance/chemotherapy and moving forwards Referred back to colorectal team locally Advised to have further discussions with oncology team 35 www.pmibasingstoke.com

A National Development Programme for all colorectal MDTs around GB and Ireland to discuss optimal referral and treatment for colorectal cancer patients with advanced disease. Programme was designed by an expert steering group with representatives from units around the UK. Aim = to help patients get the best treatment, at the best time, in the best place for them. 36 www.pmibasingstoke.com

IMPACT brings together the teams from all the units within each network, encouraging collaboration and understanding of local activity. Before the workshop every MDT is sent: a case study to discuss in their MDT asked to complete a spreadsheet with details of new CRC cases first presented in their MDT in one month (January 2015) and the outcomes of these cases 36 months later (June 2017). 37 www.pmibasingstoke.com

So far we have had three workshops: 26th January in Basingstoke 21st March in York 2nd May in Edinburgh 411 people have attended a Pelican IMPACT workshop. 38 www.pmibasingstoke.com

Colorectal lung metastases Colorectal liver metastases (surgery) Colorectal liver metastases (oncology) Colorectal peritoneal metastases / metachronous disease Colorectal T4 tumour, locally advanced primary Local recurrence of rectal cancer 39 www.pmibasingstoke.com

40 www.pmibasingstoke.com

Thank you for your attention. 41 www.pmibasingstoke.com